KANNA DOKGO: Open Payments
NPI 1760843890 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,404 in 231 payments from 27 companies in 2025. Trend: 2023 $4,998 · 2024 $5,582 · 2025 $5,404
Food & beverage: $5,404
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 29 | $866 |
| ABBVIE INC. | 29 | $650 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 16 | $606 |
| Amgen Inc. | 24 | $452 |
| Novo Nordisk Inc | 21 | $437 |
| GlaxoSmithKline, LLC. | 28 | $389 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $262 |
| Lilly USA, LLC | 10 | $238 |
| PFIZER INC. | 12 | $237 |
| Merck Sharp & Dohme LLC | 10 | $233 |
Products named: JARDIANCE, BREZTRI, Ozempic, Kerendia, AIRSUPRA, EVENITY, LINZESS, CREON.
Industry payments across HI — which companies pay providers there.
